[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $cmps

Compass Pathways receives Oppenheimer upgrade to Outperform with a $XX price target, citing conviction in COMP360 as the first FDA-approved psychedelic therapy for depression.

### About $cmps
Compass Pathways is a biotechnology company focused on developing psilocybin-based therapies for mental health.  

### Insights
- $cmps creators is up XXXXX% from the previous week.
- $cmps engagements is up XXXXX% from the previous week.
- $cmps mentions is up XXXXX% from the previous week.

### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$cmps/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$cmps/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXXX  
X Week: XXXXXX +65%  
X Month: XXXXXXX +18%  
X Months: XXXXXXXXX +17%  
X Year: XXXXXXXXX +76%  
1-Year High: XXXXXXX on 2025-06-23  
1-Year Low: XXX on 2025-10-26  

Engagements by network (24h):
X: XXXXX

  
  
### Mentions: XXX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$cmps/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$cmps/time-series/posts_active.tsv)  
Current Value: XXX  
Daily Average: XX  
X Week: XXX +93%  
X Month: XXX -XX%  
X Months: XXXXX +205%  
X Year: XXXXX +306%  
1-Year High: XXX on 2025-06-24  
1-Year Low: X on 2025-12-07  

Mentions by network (24h):
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$cmps/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$cmps/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $cmps in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX +80%  
X Month: XXX -XX%  
X Months: XXXXX +430%  
X Year: XXXXX +193%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-12-07  

The most influential creators that mention $cmps in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@PsychedVantage](/creator/twitter/PsychedVantage)   | X    | XXXXX     | XX    | XXX         |
| [@seedy19tron](/creator/twitter/seedy19tron)         | X    | XXXXX     | X     | XXX         |
| [@PsychedStocks](/creator/twitter/PsychedStocks)     | X    | XXX       | XX    | XXX         |
| [@notpowellss___](/creator/twitter/notpowellss___)   | X    | XXX       | X     | XXX         |
| [@KCTrades777](/creator/twitter/KCTrades777)         | X    | XXXXXX    | X     | XXX         |
| [@seedytx19](/creator/twitter/seedytx19)             | X    | XXXXX     | X     | XXX         |
| [@zohmbastic](/creator/twitter/zohmbastic)           | X    | XXXXX     | X     | XXX         |
| [@salmaogs](/creator/twitter/salmaogs)               | X    | XXXXXX    | X     | XX          |
| [@TheTradeParadox](/creator/twitter/TheTradeParadox) | X    | XXX       | X     | XX          |
| [@flobrand](/creator/twitter/flobrand)               | XX   | XXXXX     | X     | XX          |

[View More](/list/creators/$cmps/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cmps/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$cmps/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -XX%  
X Month: XX% -XX%  
X Months: XX% -X%  
X Year: XX% -XX%  
1-Year High: XXX% on 2024-12-23  
1-Year Low: XX% on 2025-03-31  

Most Supportive Themes:
- CYBN CYB003 Phase X Data: (30%) Cybin's CYB003 Phase X trial data shows promising efficacy for depression treatment, boosting investor confidence and highlighting the potential of psychedelic medicines.
- Psychedelic Sector Growth: (25%) The psychedelic sector is experiencing increased investor interest and institutional attention, driven by positive trial data and the potential for revolutionary mental health treatments.
- Compass Pathways R&D Collaboration: (15%) Compass Pathways is entering into R&D collaborations to pioneer precision treatments for various conditions, indicating advancements in their therapeutic development.
  
Most Critical Themes:
  

### Top $cmps Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"i bought $CMPS at $XXXX and later sold when it was XX% up. it was down on good earning reports. its $XXXX now. what a great XXX% gain before slight fell"  
[X Link](https://x.com/Gubloinvestor/status/1999596815306424810) [@Gubloinvestor](/creator/x/Gubloinvestor) 2025-12-12T21:46Z 2582 followers, 1077 engagements


"$CLOV $CMPS ⚠👀 Guys Don't miss the next move in a few hours 💸➡"  
[X Link](https://x.com/Floran89992/status/1999519350454386790) [@Floran89992](/creator/x/Floran89992) 2025-12-12T16:38Z XX followers, XXX engagements


"Looks like $CMPS might finally be turning around. 🍄😋"  
[X Link](https://x.com/quickshiftinn/status/1999516604803985589) [@quickshiftinn](/creator/x/quickshiftinn) 2025-12-12T16:28Z XXX followers, XX engagements


"$CMPS hit the XX week high today $XXXX now"  
[X Link](https://x.com/notpowellss___/status/1999494301286338766) [@notpowellss___](/creator/x/notpowellss___) 2025-12-12T14:59Z XXX followers, XXX engagements